Management of malignant pleural effusion by multimodality treatment including the use of paclitaxel administered by 24-hour intrathoracic infusion for patients with carcinomatous pleuritis

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 1, 2006, Pages 15-19

  Ohta, Yasuhiko ^a,b   Shimizu, Y ^a   Matsumoto, ^a   Watanabe, G ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b ISHIKAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Carcinomatous pleuritis; Lung cancer; Malignant pleural effusion; Paclitaxel

Indexed keywords

ANTINEOPLASTIC AGENT; PACLITAXEL;

ARTICLE; BREAST TUMOR; CANCER STAGING; CANCER SURGERY; CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; HUMAN; LUNG CANCER; LUNG TUMOR; MULTIMODALITY CANCER THERAPY; NEUTROPENIA; PLEURA EFFUSION; PLEURISY; PRIORITY JOURNAL; THORACOTOMY; THORAX PAIN; TOXICITY;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PACLITAXEL; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; PLEURAL NEOPLASMS; PLEURISY; TIME FACTORS; TREATMENT OUTCOME;

EID: 33646085328     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. The Japan Lung Cancer Society. General Rules for Clinical and Pathological Record of Lung Cancer. 6th ed. Tokyo: Kanehara, 2003.
2. Perng R.P., Wu M.F., Lin S.H., Chen Y.M., Lin J.Y., Whang-Peng J.: A phase I feasibility and pharmokokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions. Anti-Cancer Drugs. 8: 563-573, 1997.
3. Perng R.P., Chen Y.M., Wu M.F., et al: Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions. Respiratory Medicine. 92: 473-479, 1998.
4. Ohta Y., Tanaka Y., Kara T., et al.: Clinicopathplogical and biological assessment of lung cancers with pleural dissemination. Ann. Thorac. Surg. 69: 1025-1029, 2000.
5. Sawabata N., Matsumura A., Motohiro A., et al. Malignant minor pleural effusion detected on thoracotomy for patients with non-small cell lung cancer: Is tumor resection beneficial for prognosis? Ann. Thorac. Surg. 73: 412-415, 2002.
6. Bernard A., de Dompsure R.B., Hagry O., Faver J.P.: Early and late mortality after pleurodosis for malignant pleural effusion. Ann. Thorac. Surg. 74: 213-217, 2002.
7. Frank A., Baciewicz Jr.: Malignant pleural effusion. In: Pass HI, Mitchell J, Johnson DH, Turrisi AT, Minna JD, eds. Lung cancer principles and practice. Philadelphia, Lippincott Williams & Wilkins 2000: 1027-1037.
8. Zebrowski BK., Yano S., Liu W., et al: Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. Clin. Cancer Res. 5: 3364-3368, 1999.
9. Thickett DR., Armstrong L., Millar AB.: Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions. Thorax. 54: 707-710, 1999.